New Zealand markets closed

Entrada Therapeutics, Inc. (TRDA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
15.59-0.15 (-0.95%)
At close: 04:00PM EDT
15.59 0.00 (0.00%)
After hours: 04:25PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 527.99M
Enterprise value 267.01M
Trailing P/E 22.67
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.23
Price/book (mrq)1.96
Enterprise value/revenue 1.64
Enterprise value/EBITDA 9.90

Trading information

Stock price history

Beta (5Y monthly) -0.23
52-week change 3-3.77%
S&P500 52-week change 322.70%
52-week high 318.44
52-week low 310.75
50-day moving average 314.02
200-day moving average 314.45

Share statistics

Avg vol (3-month) 373.96k
Avg vol (10-day) 378.67k
Shares outstanding 533.76M
Implied shares outstanding 633.76M
Float 813.21M
% held by insiders 114.32%
% held by institutions 177.49%
Shares short (15 May 2024) 41.66M
Short ratio (15 May 2024) 424.54
Short % of float (15 May 2024) 48.43%
Short % of shares outstanding (15 May 2024) 44.92%
Shares short (prior month 15 Apr 2024) 41.75M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 14.42%
Operating margin (ttm)35.71%

Management effectiveness

Return on assets (ttm)3.01%
Return on equity (ttm)9.41%

Income statement

Revenue (ttm)162.87M
Revenue per share (ttm)4.89
Quarterly revenue growth (yoy)134.00%
Gross profit (ttm)N/A
EBITDA 26.96M
Net income avi to common (ttm)23.48M
Diluted EPS (ttm)0.69
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)327.41M
Total cash per share (mrq)10.31
Total debt (mrq)66.43M
Total debt/equity (mrq)24.66%
Current ratio (mrq)2.38
Book value per share (mrq)8.52

Cash flow statement

Operating cash flow (ttm)-89.11M
Levered free cash flow (ttm)-11.74M